Senti Biosciences (SNTI) Files $300M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Form S-3 Senti Biosciences, Inc.
March 21, 2025 6:13 AM EDTAs filed with the Securities and Exchange Commission on March 20, 2025... More
Form S-3 Senti Biosciences, Inc.
March 21, 2025 6:07 AM EDTAs filed with the Securities and Exchange Commission on March 20, 2025 Registration No. 333- ... More
